Navigation Links
BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors
Date:12/9/2009

BIRMINGHAM, Ala., Dec. 9 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Charles A. Sanders, M.D. has been elected to the Company's Board of Directors. Dr. Sanders brings to BioCryst extensive experience as a corporate executive and director, physician and professor of medicine.

"We are pleased to welcome Dr. Sanders to BioCryst's Board of Directors," said Zola P. Horovitz, Ph.D., Chairman of the Board of BioCryst Pharmaceuticals. "Charlie's strong track record of building and transforming leading pharmaceutical companies and his diverse knowledge of our industry and medical practice will be invaluable to the management of BioCryst as the Company's leading clinical programs move toward completion."

"BioCryst has gone through a significant transformation to become a late-stage development company with its first product sales," said Dr. Sanders. "I look forward to sharing my experiences with the leadership of the Company as they prepare peramivir and forodesine for commercial launch and continue their work to build an enduring successful pharmaceutical company."

Dr. Sanders is retired from Glaxo, Inc., where he served as Chief Executive Officer from 1989 through 1994 and Chairman of the Board from 1992 through 1995. Before joining Glaxo, Inc., Dr. Sanders spent eight years with Squibb Corp., where he held a number of posts, including the position of Vice Chairman. He also served as Chief Executive Officer of the Science and Technology Group and Chairman of the Science and Technology Committee of the Board. Previously Dr. Sanders was General Director of Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. A native of Dallas, he is a graduate of Southwestern Medical College of the University of Texas.

Dr. Sanders is pas
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
2. BioCryst Provides Forodesine HCl Update
3. BioCryst Updates Peramivir Clinical Development Plan
4. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
5. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
6. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
7. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
8. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
9. BioCryst Provides Update Regarding Peramivir for Influenza
10. BioCryst Clarifies Government Declaration Regarding Peramivir
11. BioCryst to Present at JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... and MENLO PARK, Calif. , Sept. ... DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused ... today announced its financial results for the fiscal year ... recent Company highlights and expected near-term milestones. ... conference call and live webcast for investors, analysts and ...
(Date:9/3/2015)... -- Cipla, a global pharmaceutical company which uses technology and ... today announced that its UK arm, Cipla EU has ... InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc. The transaction ... $550 million and will be an all cash transaction. ... million for the year ended Dec 2014 and over ...
(Date:9/3/2015)... -- Report Details What can be expected ... to grow at the fastest rates? Visiongain,s brand new ... trends, opportunities and prospects there. Our 205-page ... most lucrative areas in the industry and the future ... sales at overall world market and regional level. You ...
Breaking Medicine Technology:DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4
... RENSSELAER, N.Y., Oct. 26 The Upstate New ... Hudson Mohawk Section of the American Society of ... symposium and exhibition on Wednesday, October 27, 2010 ... Assistant Professor, Rensselaer Polytechnic Institute and Seth Cohen, ...
... 26 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ... CSKI ), a leading fully integrated ... ("PRC"), today announced that it has submitted, jointly ... application to China,s State Food and Drug Administration ...
Cached Medicine Technology:Upstate New York Laboratory Robotics Interest Group (LRIG) to Host Free Symposium and Exhibition 2China Sky One Medical Applies for Production Licenses of 15 New Medical Products 2China Sky One Medical Applies for Production Licenses of 15 New Medical Products 3
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article ... the American Dental Association presented data showing that it is safe for pregnant women ... pregnant women that had undergone local anesthesia with a group that hadn’t, researchers were ...
(Date:9/4/2015)... ... ... The Providence Fertility Center will host a Fertility Cocktail Hour" in Providence ... Date and Time: October 8, 2015 at Waterman Grille restaurant and lounge, 4 Richmond ... discuss the basics of female fertility and egg freezing, and offer women a chance ...
(Date:9/4/2015)... ... September 04, 2015 , ... A Union ... Project. Core Compassion Project is a non-profit organization dedicated to offering Pilates ... effects of cancer treatments and recover their mobility, strength, and range of motion ...
(Date:9/4/2015)... ... ... Mike Day, a former Navy SEAL who was shot 27 times during a ... on October 10th. , Mike is running the race to raise awareness and funding ... treatments that restore their quality of life. More than 300,000 post 9/11 ...
(Date:9/4/2015)... ... September 04, 2015 , ... Having access to a doctor can ... an increasing amount of unnecessary emergency room visits which affects hospitals’ abilities to provide ... health bill. Fortunately, a solution to alleviate this problem has recently presented itself, the ...
Breaking Medicine News(10 mins):Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3
... Guidance Reflecting Growth of 27-29 Percent over ... 2007 First-Quarter Year-Over-Year Highlights (adjusted for ... two-for-one stock split): ... to $0.55 from $0.52, excluding $0.05 in amortization of ...
... an 89% initial success,rate in arresting or eradicating ... is being offered to the public for the ... Dr. Stephen,Cantrell, gathering more data to validate effectiveness ... This treatment has been effective,for malignant melanoma, as ...
... M.D., announced today,the appointment of Nancy Sclater as ... Cancer Research, a unique organization that partners,with Swedish ... "We are thrilled that Nancy has joined ... against ovarian cancer. Her leadership will be,instrumental in ...
... Inc. has received a,Small Business Innovative Research ... to continue the testing and development of ... throughput assay system. The,pioneering research performed by ... that allow the rapid development of revolutionary,insect ...
... Insights on What Key Issues Matter Most to Women and ... in Shaping the Upcoming Presidential Election, NEW YORK, April ... leading media companies, Meredith Corporation,(NYSE: MDP ) and NBC ... a,nationwide survey conducted among more than 3,000 women that covered ...
... appears to decline along with weight, study finds , , ... surgery that reduced the amount of food they could ingest ... lower back pain, according to a new report. , ... gastric bypass surgery reported that their pain decreased by an ...
Cached Medicine News:Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 2Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 3Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 4Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 5Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 6Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 7Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 8Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 9Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 10Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 11Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 12Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 13Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 14Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 15Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 16Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 17Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 18Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 19Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 20Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 21Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 22Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 23Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 24Health News:Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates 25Health News:New Treatment Offers Hope for Beating Aggressive Cancers 2Health News:Seattle-Based Marsha Rivkin Center for Ovarian Cancer Research Appoints Nancy Sclater, Executive Director 2Health News:Inscent, Inc. Receives Federal Grant to Develop Honeybee Repellents 2Health News:Study Reveals Women Feeling Growing Financial Pressures on Family Life 2Health News:Study Reveals Women Feeling Growing Financial Pressures on Family Life 3Health News:Study Reveals Women Feeling Growing Financial Pressures on Family Life 4Health News:Study Reveals Women Feeling Growing Financial Pressures on Family Life 5Health News:Study Reveals Women Feeling Growing Financial Pressures on Family Life 6Health News:Gastric Bypass May Also Relieve Low Back Pain 2
... complete line of Surgical Access ...unlike any ... OnePort™ trocar system is actually four systems ... operationally flexible and clinically adaptive to all ... in disposability and bladed or dilating tip ...
Mini-Finesse 5mm Dilating Trocar, hook electrode, two lengths, mini or basic kit....
... The Thoracic Trocar Sleeve consists ... which is designed to prevent ... structures once the cavity has ... stability threads on the sleeve ...
... The TRISTAR is a full-featured trocar that consists ... The shield is designed to cover the pyramidal ... laceration once the abdominal or thoracic cavity has ... excessive force to insert is not required. , ...
Medicine Products: